Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

TEG 6s Hemostasis System Citrated: K, KH, RT, FF Assay Cartridge

K-Number: K251024 · 2025-04-30

ApplicantHaemonetics
Decision Date2025-04-30
Product CodeJPA
Advisory CommitteeHE
DecisionSubstantially Equivalent

Device Summary

TEG 6s Hemostasis System Citrated: K, KH, RT, FF Assay Cartridge is a medical device manufactured by Haemonetics. It received FDA 510(k) clearance on 2025-04-30 under approval number K251024. The device is classified under product code JPA. It was reviewed by the HE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the TEG 6s Hemostasis System Citrated: K, KH, RT, FF Assay Cartridge?

TEG 6s Hemostasis System Citrated: K, KH, RT, FF Assay Cartridge is a medical device that received FDA 510(k) clearance on 2025-04-30. It is manufactured by Haemonetics. The 510(k) number is K251024.

When was TEG 6s Hemostasis System Citrated: K, KH, RT, FF Assay Cartridge approved by the FDA?

TEG 6s Hemostasis System Citrated: K, KH, RT, FF Assay Cartridge received FDA 510(k) clearance on 2025-04-30, under approval number K251024.

What company makes TEG 6s Hemostasis System Citrated: K, KH, RT, FF Assay Cartridge?

TEG 6s Hemostasis System Citrated: K, KH, RT, FF Assay Cartridge is manufactured by Haemonetics.

What is the FDA product code for TEG 6s Hemostasis System Citrated: K, KH, RT, FF Assay Cartridge?

The FDA product code for TEG 6s Hemostasis System Citrated: K, KH, RT, FF Assay Cartridge is JPA.

Related Clinical Trials

Related PubMed Literature

Related Devices (Code: JPA)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.